Midkine Promotes Metastasis and Therapeutic Resistance via mTOR/RPS6 in Uveal Melanoma.
Margarete M KargLukas JohnNasrin RefaianChristian BuettnerTanja RottmarJonas SommerBarbara BockYazid J ResheqBruce R KsanderLudwig M HeindlAndreas MackensenJacobus J BoschPublished in: Molecular cancer research : MCR (2022)
Midkine is identified as a survival factor that drives liver metastasis and therapeutic resistance in melanoma of the eye.
Keyphrases